<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors report the results of inhibition of <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> synthetase in 49 consecutive patients with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="1" pm="."><plain>These unselected Grade I to IV patients <z:hpo ids='HP_0000001'>all</z:hpo> had a ruptured <z:hpo ids='HP_0002617'>aneurysm</z:hpo> of the anterior circle of Willis, and were operated on within 72 hours after SAH </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-seven patients were treated postoperatively by an intravenous infusion of <z:chebi fb="199" ids="26708">sodium</z:chebi> (E)-3- [4-(3-pyridylmethyl)-<z:chebi fb="1" ids="30396">phenyl</z:chebi>] -2- <z:chebi fb="0" ids="37080">propenoate</z:chebi> (OKY-1581), a selective inhibitor of <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> synthetase, at 5 micrograms/kg/min for 10 to 14 days, and the remaining 22 patients did not receive this drug </plain></SENT>
<SENT sid="3" pm="."><plain>Both groups of patients had similar age distribution and preoperative neurological conditions </plain></SENT>
<SENT sid="4" pm="."><plain>A suggestive but statistically insignificant improvement was found in postoperative angiographic vasospasm, ischemic symptoms, and overall outcome in the group receiving OKY-1581 </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of low-density areas on the postoperative computerized tomography scans was significantly decreased in patients treated with OKY-1581 infusion </plain></SENT>
</text></document>